Home › Funds › Ikarian Capital, LLC › CUE
Ikarian Capital, LLC position in CUE
CUE BIOPHARMA INC · Health Care
Ikarian Capital, LLC reported holding 290,633 shares of CUE (CUE BIOPHARMA INC) in its Q3 2026 13F filing — a position valued at US$7.5M, representing 1.10% of its reported portfolio and ranking #21 among its reported holdings. Ikarian Capital, LLC has disclosed CUE holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Ikarian Capital, LLC's CUE position evolved
Ikarian Capital, LLC first disclosed a stake in CUE in Q2 2026 at 104,364 shares (US$3.3M). The position peaked in Q3 2026 at 290,633 shares, worth US$7.5M. Across 2 filings, Ikarian Capital, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 290,633 shares valued at US$7.5M — an increase of 186,269 shares quarter over quarter.. Notable position changes include a 178% increase in Q3 2026 (shares fell 45% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 104.36K | $3.29M | New |
| Q3 2026 | 290.63K | $7.52M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CUE and 13F data
CUE (CUE BIOPHARMA INC) is a Health Care company. 38 other funds we track also report a position in CUE — the largest reported positions include Cormorant Asset Management, LP (US$16.2M), Bleichroeder LP (US$9.5M), Vivo Capital, LLC (US$7.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CUE
- Cormorant Asset Management, LP 625.28K sh · $16.18M · Q3 2026
- Bleichroeder LP 366.15K sh · $9.47M · Q3 2026
- Vivo Capital, LLC 280.06K sh · $7.25M · Q3 2026
- Lion Point Capital, LP 52.93K sh · $1.37M · Q3 2026
More on Ikarian Capital, LLC
FAQ
How long has Ikarian Capital, LLC held CUE?
Ikarian Capital, LLC has disclosed CUE holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Ikarian Capital, LLC's current position in CUE?
As of Q3 2026, Ikarian Capital, LLC holds 290.63K shares of CUE (CUE BIOPHARMA INC), valued at $7.52M, representing 1.10% of its reported portfolio and ranking #21.
Has Ikarian Capital, LLC been buying or selling CUE?
In the latest 13F filing (Q3 2026), Ikarian Capital, LLC increased its position in CUE. The position peaked in Q3 2026 at 290.63K shares.
Which other funds hold CUE?
Other major institutional holders of CUE include Cormorant Asset Management, LP, Bleichroeder LP, Vivo Capital, LLC, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.